A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)

Inclusion Criteria: * History of physician diagnosed GERD * Heartburn and Regurgitation 3 Days during the week prior to screening Exclusion Criteria: * History of erosive esophagitis, Barrett's esophagus, esophageal stricture, scleroderma, Zollinger-Ellison Syndrome, known primary disorder * History or presence of infection or inflammation of the small or large intestine, gastrointestinal malignancy, history of upper GI surgery * Use of PPI during the last four weeks prior to screening Other protocol-defined inclusion/exclusion criteria may apply.